Maternal flu vaccination and healthy beginnings

Influenza during pregnancy can be more serious than an ordinary seasonal illness. Changes to the immune system, heart and lungs help support pregnancy, but they can also increase the risk of severe respiratory disease, hospital admission and complications from influenza. Vaccination gives the pregnant person protection while also helping shield the baby during the first months after birth.

The evidence on maternal influenza immunisation covers several outcomes: miscarriage, congenital anomalies, preterm birth, birth weight, stillbirth, newborn infection and hospitalisation in infancy. Large studies and safety surveillance have generally been reassuring, although researchers continue to monitor results across different seasons, vaccine types and populations.

For families in Australia, timing and access matter. Influenza viruses circulate most heavily during the cooler months, often from April to September, but outbreaks can occur earlier or later. A pregnant person in Sydney, Melbourne, Brisbane or a regional community may encounter the virus through public transport, work, school-aged children or busy indoor settings before the peak season arrives.

The FAOPS 2020 congress website was associated with a scientific meeting on perinatal and neonatal medicine in Tokyo that was cancelled in April 2020 because of the COVID-19 pandemic. Its subject area remains relevant: preventing infection during pregnancy is closely connected with maternal health, fetal wellbeing and neonatal care.

Why influenza matters during pregnancy

Influenza can cause high fever, dehydration, pneumonia and worsening of asthma or other respiratory conditions. Pregnancy itself places extra demands on circulation and breathing, so an infection that might be manageable for a non-pregnant adult can become more demanding during gestation. Severe illness may require hospital treatment and can affect fetal wellbeing through fever, reduced oxygenation or maternal complications.

The risk is not identical for every person. Asthma, diabetes, heart disease, immune suppression and higher body weight may increase the chance of complications, as can limited access to early medical care. Aboriginal and Torres Strait Islander families may also face unequal access to preventive services, particularly in rural and remote areas. Culturally safe, local maternity and primary care services are important parts of prevention.

Influenza vaccination does not guarantee that infection will never occur. Its value is that it reduces the chance of severe disease and can lessen the impact of infection when a vaccinated person is exposed. Prompt antiviral treatment may also be recommended for a pregnant person with suspected influenza, since treatment is generally most effective when started early.

How protection reaches the baby

During pregnancy, the immune system responds to the vaccine by producing influenza-specific antibodies. These antibodies circulate in the pregnant person’s blood and can cross the placenta, particularly later in pregnancy. The newborn therefore begins life with some passive protection without receiving a live influenza virus from the vaccine.

This protection is especially relevant because babies younger than six months are too young for routine influenza vaccination in Australia. They depend on maternal antibodies, reduced exposure and vaccination of close household contacts. Breastfeeding can provide additional immune benefits, although it should not be treated as a substitute for maternal immunisation or clinical care.

The level of protection varies according to the influenza strains included in the seasonal vaccine, how well those strains match viruses in circulation, the timing of vaccination and the infant’s age. Even when protection is incomplete, reducing the likelihood of emergency visits or hospitalisation can be clinically meaningful for a young baby.

Fetal outcomes and pregnancy safety

Available research has not identified a credible increase in miscarriage, stillbirth or major birth defects following recommended inactivated influenza vaccination during pregnancy. Observational studies can be affected by factors such as the timing of vaccination, underlying illness and whether a person seeks care, but results across large datasets have been broadly reassuring.

Some studies report lower rates of preterm birth or small-for-gestational-age birth among vaccinated groups. These findings may partly reflect prevention of severe influenza and fever, although they do not prove that vaccination directly improves every pregnancy outcome. The strongest practical message is that avoiding serious maternal infection may reduce pathways that can place stress on the fetus.

Australian guidance recommends influenza vaccination during any trimester, including the first trimester, when it is indicated. A person who was vaccinated before becoming pregnant does not generally need to repeat the dose solely because pregnancy has begun, although seasonal recommendations and personal circumstances should be checked with a health professional.

The vaccine used for pregnancy is not a live influenza vaccine. Temporary soreness, fatigue, headache or a mild fever can occur. A severe allergic reaction is rare, but anyone with a previous vaccine reaction or a history of anaphylaxis should discuss the product and ingredients with their GP, midwife or immunisation provider.

What infant outcomes may improve

Maternal immunisation has been associated with fewer laboratory-confirmed influenza infections in young infants and fewer influenza-related hospital presentations. This matters during the period when babies are developing their own immune responses and are not yet eligible for routine influenza vaccination.

A protected mother may also be less likely to become seriously ill while caring for a newborn. That can support feeding, bonding and attendance at early postnatal appointments. It may reduce the chance that a baby is exposed to a parent who requires hospital care or has difficulty maintaining ordinary infection-control practices.

Parents should still watch for warning signs in a newborn, including breathing difficulty, poor feeding, unusual sleepiness, dehydration or a temperature concern. Medical assessment should be sought promptly when a young infant appears unwell. Broader neonatal problems require separate assessment; for example, clinicians may draw on resources about neonatal obstruction care when gastrointestinal symptoms suggest a structural or functional issue rather than influenza.

Access and decisions in Australia

Influenza vaccination is recommended for pregnant people in Australia and is available through the National Immunisation Program, subject to current eligibility and delivery arrangements. GPs, antenatal clinics, Aboriginal Community Controlled Health Organisations and some community pharmacies may provide vaccination. Pharmacy services and age or pregnancy requirements can vary by state or territory, so local availability should be checked before attending.

The Australian Immunisation Handbook provides national clinical guidance, while the Therapeutic Goods Administration regulates approved vaccines under Australia’s therapeutic goods framework. These systems cover product quality, safety monitoring and recommendations; they do not remove the need for individual consent and clinical assessment. A person should receive clear information about benefits, possible adverse effects and alternatives when discussing vaccination.

The local market can influence access. Private flu clinics and pharmacy appointments may be convenient for people working in central Melbourne or commuting across Sydney, while rural families may need to coordinate vaccination with a GP visit, community nurse or antenatal appointment. Medicare arrangements, supply and state-based pharmacy rules can change, so the provider should confirm current fees and eligibility.

Prevention also works alongside infection-control habits. Hand hygiene, staying home when unwell, improving ventilation and avoiding close contact with people who have respiratory symptoms can reduce exposure. These measures are particularly useful in households with preschool children, where viruses can move quickly between childcare, public transport and home.

Recognising illness and acting early

Vaccination is preventive care, not a treatment for influenza that has already developed. Fever, chills, cough, sore throat, muscle aches, headache and marked fatigue should prompt a pregnant person to contact a GP, midwife or maternity service. Shortness of breath, chest pain, confusion, fainting, severe dehydration or rapidly worsening symptoms require urgent medical attention.

Pregnancy can alter the usual presentation of illness, and waiting for a test result may delay treatment. A clinician may recommend an antiviral medicine based on symptoms, exposure and local influenza activity. The risks of untreated influenza should be considered alongside the safety profile and timing of any recommended medicine.

Maternal infection can occur alongside other serious conditions. Sepsis, for example, can develop from several sources and requires rapid recognition rather than assuming every fever is uncomplicated influenza. Information on maternal sepsis guidance can help place fever, rapid breathing, confusion and other warning signs in a broader maternity safety context.

Planning vaccination around everyday life

Before vaccination:

• Check the current seasonal recommendation with a GP, midwife or pharmacist.
• Mention allergies, previous vaccine reactions and relevant medical conditions.
• Arrange vaccination before peak winter circulation when possible.

After vaccination:

• Expect possible short-term soreness or tiredness.
• Continue hand hygiene and avoid close contact with people who are unwell.
• Seek care for severe symptoms or a suspected allergic reaction.

Making a well-informed choice

Maternal influenza vaccination is supported by a substantial body of safety and effectiveness evidence. The main benefits are lower risk of severe influenza for the pregnant person and passive antibody protection for the newborn. Evidence about outcomes such as preterm birth and birth weight is encouraging in some studies, but vaccination should be presented accurately: it is an important infection-prevention measure, not a guarantee of every pregnancy outcome.

A personal discussion is worthwhile when there is a history of severe allergy, immune compromise, complex pregnancy, previous adverse reactions or uncertainty about which vaccine was given. The decision can be incorporated into a routine antenatal visit, a pharmacy appointment or a seasonal vaccination service. Keeping the child’s immunisation plan and household vaccination status current adds another layer of protection after birth.

Australian families can speak with their GP, midwife, obstetrician, Aboriginal health service or pharmacist about the current influenza season, vaccine availability and any individual precautions. Arranging that conversation early can help protect pregnancy, support a safer start for the baby and reduce avoidable pressure on families and hospitals during winter.